Mashima, Yukihiko <br/><br/>
Visual prognosis better in eyes with less severe reduction of visual acuity one year after onset of Leber hereditary optic neuropathy caused by the 11,778 mutation.  [electronic resource] 

 -  BMC ophthalmology  Oct 2017 
 - 192 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1471-2415 
<br/><br/><label>Standard No.: </label>10.1186/s12886-017-0583-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Age of Onset<br/>Aged<br/>Antioxidants--therapeutic use<br/>Ascorbic Acid--therapeutic use<br/>Child<br/>DNA Mutational Analysis<br/>DNA, Mitochondrial--genetics<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Optic Atrophy, Hereditary, Leber--drug therapy<br/>Point Mutation<br/>Polymerase Chain Reaction<br/>Prognosis<br/>Recovery of Function--physiology<br/>Retrospective Studies<br/>Riboflavin--therapeutic use<br/>Ubiquinone--analogs & derivatives<br/>Vision Disorders--drug therapy<br/>Visual Acuity--physiology<br/>Visual Field Tests<br/>Vitamin B Complex--therapeutic use<br/>Young Adult